Respuesta a la talidomida en escleromixedema. / [Response to thalidomide in scleromyxedema].
Medicina (B Aires)
; 73(3): 252-4, 2013.
Artigo
em Espanhol
| BINACIS
| ID: bin-133084
ABSTRACT
The scleromyxedema is a rare condition characterized by hyperproliferation of fibroblasts with increased dermal deposition of mucin and frequently associated with monoclonal gammopathy of undetermined significance. Various treatments have been reported, with inconsistent results. In addition, the rarity of the disease and the lack of randomized controlled trials results in treatment options derived from anecdotal reports. We describe the case of a 52 year-old female patient diagnosed with scleromyxedema who developed a monoclonal gammopathy, with adequate response to thalidomide. The follow up of these patients is important due to the risk of progression to multiple myeloma and complications related to systemic treatments.
Buscar no Google
Coleções:
Bases de dados nacionais
/
Argentina
Base de dados:
BINACIS
Assunto principal:
Talidomida
/
Escleromixedema
/
Imunossupressores
Tipo de estudo:
Ensaio clínico controlado
/
Estudo diagnóstico
/
Estudo de etiologia
Idioma:
Espanhol
Revista:
Medicina (B Aires)
Ano de publicação:
2013
Tipo de documento:
Artigo